NCT01719367View on ClinicalTrials.gov

Genetically Determined Response to Atenolol in Patients With Persistent Atrial Fibrillation

NACompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Atrial Fibrillation
Interventions
DRUG

Atenolol

Trial Locations (1)

37232

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
lead

Vanderbilt University Medical Center

OTHER

NCT01719367 - Genetically Determined Response to Atenolol in Patients With Persistent Atrial Fibrillation | Biotech Hunter | Biotech Hunter